compounding semaglutide news FDA issues warning about some compounded versions of for diabetes, weight loss Semaglutide injections will no longer

In the meantime, we expect the MedTech sector to hunker down and demonstrate to patients, payors, and investors how their therapies can be used in concert with GLP-1s, and consider how their total addressable markets may increase as new patients become eligible for procedures they may previously not have been candidates for.

Menopausal HRT is a candidate treatment strategy for MASLD

Disclaimer: This article is educational and is not medical, tax, or benefits advice

W., Schoenherr, J., Gouker, L., & Lund, E

Patients have the greatest chances of success when these medications are paired with lifestyle changes and collaboration with their health care provider. But Byers said limiting coverage for everyone hurts people like her, who are consistent in taking the medications and have made significant lifestyle changes